CliffBio
small molecule

HALOBETASOL PROPIONATE

HALOBETASOL PROPIONATE

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameHALOBETASOL PROPIONATE
Active ingredientHALOBETASOL PROPIONATE
Strength0.05%
Dosage formOINTMENT
RouteTOPICAL
ModalitySmall molecule
FDA approvalSeptember 2006
Marketing statusDISCN

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.